# Multicenter Trial for Adults With Partial Seizures

> **NCT00034814** · PHASE2 · COMPLETED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 190 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Talampanel
- **DRUG:** Placebo
- **DRUG:** Talampanel
- **DRUG:** Talampanel
- **DRUG:** Placebo
- **DRUG:** Talampanel

## Key facts

- **NCT ID:** NCT00034814
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2006-01
- **Final completion:** 2006-01
- **Target enrollment:** 190 (ACTUAL)
- **Last updated:** 2011-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00034814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00034814, "Multicenter Trial for Adults With Partial Seizures". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00034814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*